TriSalus Life Sciences (TLSI) Interest Coverage Ratio Growth (1y) (2022 - 2026)
TriSalus Life Sciences (TLSI) Interest Coverage Ratio Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 189.50% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn | -6.18% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn | -54.61% |
| 10 | TriSalus Life Sciences | 222.70 Mn | 166.14 Mn | 7.67 Mn | 3.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.38% |
| Dec 31, 2025 | -100.10% |
| Sep 30, 2025 | 21.47% |
| Jun 30, 2025 | 73.21% |
| Mar 31, 2025 | 97.35% |
| Dec 31, 2024 | 138.00% |
| Sep 30, 2024 | 99.84% |
| Jun 30, 2024 | 99.36% |
| Mar 31, 2024 | 88.69% |
| Dec 31, 2023 | -10,333.04% |
| Dec 31, 2022 | -1,448.54% |